Authors: Bear, HD Roberts, J Cornell, D Tombes, MB Kyle, B

Citation: Hd. Bear et al., Adoptive immunotherapy of cancer with pharmacologically activated lymph node lymphocytes: a pilot clinical trial, CANCER IMMU, 50(5), 2001, pp. 269-274

Authors: Roberts, JD Shibata, S Spicer, DV McLeod, HL Tombes, MB Kyle, B Carroll, M Sheedy, B Collier, MA Pithavala, YK Paradiso, LJ Clendeninn, NJ

Citation: Jd. Roberts et al., Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks, CANC CHEMOT, 45(5), 2000, pp. 423-427

Authors: Roberts, JD Poplin, EA Tombes, MB Kyle, B Spicer, DV Grant, S Synold, T Moran, R

Citation: Jd. Roberts et al., Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation, CANC CHEMOT, 45(2), 2000, pp. 103-110

Authors: Tutsch, KD Arzoomanian, RZ Alberti, D Tombes, MB Feierabend, C Robins, HI Spriggs, DR Wilding, G

Citation: Kd. Tutsch et al., Phase I clinical and pharmacokinetic study of an one-hour infusion of ormaplatin (NSC 363812), INV NEW DR, 17(1), 1999, pp. 63-72